Patient & Survivor Care
From the Journals
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All Matter
New study sheds light on quality of life effects related to disease severity and treatment choice.
Conference Coverage
The Case for Biomarker Testing in Gastroesophageal Cancer
Expert provides top three picks for biomarker testing for treatment selection.
Conference Coverage
Hepatic infusion pumps: New enthusiasm for an old technology
The response with the pump is “clearly superior” to systemic treatment, according to the author a new study.
Conference Coverage
Targeted Colorectal Cancer Combo Improves QoL
The results of a new trial may point the way to other dual therapies involving kinase inhibitors, says expert.
Conference Coverage
Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC
The findings of a new study indicate that nivolumab plus ipilimumab should really be “a new standard,” a medical oncologist says.
From the Journals
Advantage of Abemaciclib Plus Endocrine Therapy for Early Breast Cancer Endures at 5 Years
Patients with breast cancer with a high risk of recurrence showed significant improvement with adjuvant abemaciclib compared with endocrine...
Feature
Radiation Oncologists Fight for Payment Reform Amid Cuts
Over the past decade, radiation oncologists have seen a 23% drop in Medicare reimbursement for...
From the Journals
Standard Therapy Beats Out Primary Surgery in Rectal Cancer
A new study tests whether patients with locally advanced rectal cancer with MRI-predicted negative mesorectal fascia can skip preoperative...
Feature
Oncologists Sound the Alarm About Rise of White Bagging
For years, oncologist John DiPersio had faced frustrating encounters with insurers that cover medications only through a process called white...
From the Journals
Psilocybin-Assisted Group Therapy Promising for Depression in Cancer Patients
Depression remains common in patients with cancer, and common treatment approaches have demonstrated limited success.
Feature
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.